MedTrace Logo

The Development of Child Development Checklist Multimedia System and Its Clinical Evaluation

NCT02359591 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 390

Last updated 2018-01-24

No results posted yet for this study

Summary

【Background\& Purpose】In order to early detect the problems a child might have during his/her development, an effective screening tool is of great needs. The \[Taipei City Child Development Screening checklist\] is often used to serve this process. This text version is mainly distributed to the parents to fill out during their child regular check-ups to the hospitals and clinics. The drawbacks of this checklist is that it lacks of active participation of the target population, and the text version limits its usage to people who are not familiar with Chinese characteristics, such as those new inhabitant. These lead to low screening rates therefore causing delayed early intervention. 【Purpose】The purpose of this study was to design and develop the multi-media graphic version of the \[Taipei City Child Development Screening checklist\] based on its original text version.【Method】The developed muti-media system will be checked for is validity. Thirty parents/legal guardians of children in each target age groups will be recruited randomly for the clinical reliability evaluation.

Conditions

  • Child Development Checklist

Interventions

OTHER

text-based or multimedia

subjects fills in a questionnaire regarding whether the child meets the developmental milestones for his/her developmental age.

Sponsors & Collaborators

  • Hsin-Yi Kathy Cheng

    lead OTHER

Principal Investigators

  • Chang Gung Medical Hospital Chang Gung Medical Hospital · Chang Gung Medical Hospital

Eligibility

Min Age
20 Months
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-11-30
Completion
2015-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02359591 on ClinicalTrials.gov